Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders

Brain Research Reviews

Volumn 52, Issue 2, 2006, Pages 293-304

  Akbarian, Schahram ^a   Huang, Hsien Sung ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Brain derived neurotrophic factor; GABA; Glutamic acid decarboxylase; Interneuron; Schizophrenia; Single nucleotide polymorphisms

Indexed keywords

4 AMINOBUTYRIC ACID; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE 67; GLYCOPROTEIN; MESSENGER RNA; NERVE CELL ADHESION MOLECULE; NEUROTROPHIN; REELIN;

4 AMINOBUTYRIC ACID METABOLISM; AUTISM; AUTOPSY; BIPOLAR DISORDER; BRAIN DEVELOPMENT; BRAIN REGION; CHILD PSYCHIATRY; DOPAMINERGIC TRANSMISSION; EMBRYO DEVELOPMENT; GENE EXPRESSION; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC RISK; GLUTAMATERGIC TRANSMISSION; HUMAN; MENTAL DISEASE; MENTAL PATIENT; NEUROTRANSMISSION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PSYCHIATRIC DIAGNOSIS; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; TEMPORAL CORTEX;

ANIMALS; BRAIN; DOWN-REGULATION; GAMMA-AMINOBUTYRIC ACID; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENETIC PREDISPOSITION TO DISEASE; GLUTAMATE DECARBOXYLASE; HUMANS; ISOENZYMES; MUTATION; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

EID: 33747872904     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresrev.2006.04.001     Document Type: Review

References (128)

1. Abdolmaleky H.M., Cheng K.H., Russo A., Smith C.L., Faraone S.V., Wilcox M., Shafa R., Glatt S.J., Nguyen G., Ponte J.F., Thiagalingam S., and Tsuang M.T. Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report. Am. J. Med. Genet., Part B Neuropsychiatr. Genet. 134 (2005) 60-66
2. Addington A.M., Gornick M., Duckworth J., Sporn A., Gogtay N., Bobb A., Greenstein D., Lenane M., Gochman P., Baker N., Balkissoon R., Vakkalanka R.K., Weinberger D.R., Rapoport J.L., and Straub R.E. GAD1 (2q31.1), which encodes glutamic acid decarboxylase (GAD67), is associated with childhood-onset schizophrenia and cortical gray matter volume loss. Mol. Psychiatry 10 (2005) 581-588
3. Akbarian S., Bunney Jr. W.E., Potkin S.G., Wigal S.B., Hagman J.O., Sandman C.A., and Jones E.G. Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Arch. Gen. Psychiatry 50 (1993) 169-177
4. Akbarian S., Vinuela A., Kim J.J., Potkin S.G., Bunney Jr. W.E., and Jones E.G. Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development. Arch. Gen. Psychiatry 50 (1993) 178-187
5. Akbarian S., Kim J.J., Potkin S.G., Hagman J.O., Tafazzoli A., Bunney Jr. W.E., and Jones E.G. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch. Gen. Psychiatry 52 (1995) 258-266
6. Akbarian S., Kim J.J., Potkin S.G., Hetrick W.P., Bunney Jr. W.E., and Jones E.G. Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients. Arch. Gen. Psychiatry 53 (1996) 425-436
7. Alcantara S., Pozas E., Ibanez C.F., and Soriano E. BDNF-modulated spatial organization of Cajal-Retzius and GABAergic neurons in the marginal zone plays a role in the development of cortical organization. Cereb. Cortex 16 (2006) 487-499
8. An S.J., Park S.K., Hwang I.K., Choi S.Y., Kim S.K., Kwon O.S., Jung S.J., Baek N.I., Lee H.Y., Won M.H., and Kang T.C. Gastrodin decreases immunoreactivities of gamma-aminobutyric acid shunt enzymes in the hippocampus of seizure-sensitive gerbils. J. Neurosci. Res. 71 (2003) 534-543
9. Anderson S.A., Volk D.W., and Lewis D.A. Increased density of microtubule associated protein 2-immunoreactive neurons in the prefrontal white matter of schizophrenic subjects. Schizophr. Res. 19 (1996) 111-119
10. Asada H., Kawamura Y., Maruyama K., Kume H., Ding R., Ji F.Y., Kanbara N., Kuzume H., Sanbo M., Yagi T., and Obata K. Mice lacking the 65 kDa isoform of glutamic acid decarboxylase (GAD65) maintain normal levels of GAD67 and GABA in their brains but are susceptible to seizures. Biochem. Biophys. Res. Commun. 229 (1996) 891-895
11. Asada H., Kawamura Y., Maruyama K., Kume H., Ding R.G., Kanbara N., Kuzume H., Sanbo M., Yagi T., and Obata K. Cleft palate and decreased brain gamma-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 6496-6499
12. Bacci J.J., Salin P., and Kerkerian-Le Goff L. Systemic administration of dizocilpine maleate (MK-801) or l-dopa reverses the increases in GAD65 and GAD67 mRNA expression in the globus pallidus in a rat hemiparkinsonian model. Synapse 46 (2002) 224-234
13. Barbeau D., Liang J.J., Robitalille Y., Quirion R., and Srivastava L.K. Decreased expression of the embryonic form of the neural cell adhesion molecule in schizophrenic brains. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 2785-2789
14. Baxter E.R. In: Clause T.N., and Tower D.B. (Eds). GABA in Nervous System Function (1976), Raven, New York 61-87
15. Beasley C.L., Cotter D.R., and Everall I.P. Density and distribution of white matter neurons in schizophrenia, bipolar disorder and major depressive disorder: no evidence for abnormalities of neuronal migration. Mol. Psychiatry 7 (2002) 564-570
16. Beasley C.L., Zhang Z.J., Patten I., and Reynolds G.P. Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins. Biol. Psychiatry 52 (2002) 708-715
17. Benes F.M., and Berretta S. GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 25 (2001) 1-27
18. Benes F.M., Todtenkopf M.S., Logiotatos P., and Williams M. Glutamate decarboxylase(65)-immunoreactive terminals in cingulate and prefrontal cortices of schizophrenic and bipolar brain. J. Chem. Neuroanat. 20 (2000) 259-269
19. Benson D.L., Isackson P.J., Hendry S.H., and Jones E.G. Expression of glutamic acid decarboxylase mRNA in normal and monocularly deprived cat visual cortex. Brain Res. Mol. Brain Res. 5 (1989) 279-287
20. Benson D.L., Isackson P.J., Hendry S.H., and Jones E.G. Differential gene expression for glutamic acid decarboxylase and type II calcium-calmodulin-dependent protein kinase in basal ganglia, thalamus, and hypothalamus of the monkey. J. Neurosci. 11 (1991) 1540-1564
21. Benson D.L., Huntsman M.M., and Jones E.G. Activity-dependent changes in GAD and preprotachykinin mRNAs in visual cortex of adult monkeys. Cereb. Cortex 4 (1994) 40-51
22. Blatt G.J. GABAergic cerebellar system in autism: a neuropathological and developmental perspective. Int. Rev. Neurobiol. 71 (2005) 167-178
23. Bu D.F., and Tobin A.J. The exon-intron organization of the genes (GAD1 and GAD2) encoding two human glutamate decarboxylases (GAD67 and GAD65) suggests that they derive from a common ancestral GAD. Genomics 21 (1994) 222-228
24. Bu D.F., Erlander M.G., Hitz B.C., Tillakaratne N.J., Kaufman D.L., Wagner-McPherson C.B., Evans G.A., and Tobin A.J. Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 2115-2119
25. Bunney W.E., and Bunney B.G. Evidence for a compromised dorsolateral prefrontal cortical parallel circuit in schizophrenia. Brain Res. Brain Res. Rev. 31 (2000) 138-146
26. Carboni G., Tueting P., Tremolizzo L., Sugaya I., Davis J., Costa E., and Guidotti A. Enhanced dizocilpine efficacy in heterozygous reeler mice relates to GABA turnover downregulation. Neuropharmacology 46 (2004) 1070-1081
27. Cellerino A., Maffei L., and Domenici L. The distribution of brain-derived neurotrophic factor and its receptor trkB in parvalbumin-containing neurons of the rat visual cortex. Eur. J. Neurosci. 8 (1996) 1190-1197
28. Chance S.A., Walker M., and Crow T.J. Reduced density of calbindin-immunoreactive interneurons in the planum temporale in schizophrenia. Brain Res. 1046 (2005) 32-37
29. Chertkow Y., Weinreb O., Youdim M.B., and Silver H. The effect of chronic co-administration of fluvoxamine and haloperidol compared to clozapine on the GABA system in the rat frontal cortex. Int. J. Neuropsychopharmacol. (2005) 1-10
30. Choi S.Y., Morales B., Lee H.K., and Kirkwood A. Absence of long-term depression in the visual cortex of glutamic Acid decarboxylase-65 knock-out mice. J. Neurosci. 22 (2002) 5271-5276
31. Condie B.G., Bain G., Gottlieb D.I., and Capecchi M.R. Cleft palate in mice with a targeted mutation in the gamma-aminobutyric acid-producing enzyme glutamic acid decarboxylase 67. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 11451-11455
32. Costa E., Davis J., Grayson D.R., Guidotti A., Pappas G.D., and Pesold C. Dendritic spine hypoplasticity and downregulation of reelin and GABAergic tone in schizophrenia vulnerability. Neurobiol. Dis. 8 (2001) 723-742
33. Cotrufo T., Viegi A., Berardi N., Bozzi Y., Mascia L., and Maffei L. Effects of neurotrophins on synaptic protein expression in the visual cortex of dark-reared rats. J. Neurosci. 23 (2003) 3566-3571
34. Cotter D., Landau S., Beasley C., Stevenson R., Chana G., MacMillan L., and Everall I. The density and spatial distribution of GABAergic neurons, labelled using calcium binding proteins, in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia. Biol. Psychiatry 51 (2002) 377-386
35. Coyle J.T. The GABA-glutamate connection in schizophrenia: which is the proximate cause?. Biochem. Pharmacol. 68 (2004) 1507-1514
36. Delfs J.M., Ellison G.D., Mercugliano M., and Chesselet M.F. Expression of glutamic acid decarboxylase mRNA in striatum and pallidum in an animal model of tardive dyskinesia. Exp. Neurol. 133 (1995) 175-188
37. De Luca V., Muglia P., Masellis M., Jane Dalton E., Wong G.W., and Kennedy J.L. Polymorphisms in glutamate decarboxylase genes: analysis in schizophrenia. Psychiatr. Genet. 14 (2004) 39-42
38. Dracheva S., Elhakem S.L., McGurk S.R., Davis K.L., and Haroutunian V. GAD67 and GAD65 mRNA and protein expression in cerebrocortical regions of elderly patients with schizophrenia. J. Neurosci. Res. 76 (2004) 581-592
39. Eastwood, S.L., Harrison, P.J., 2003. Interstitial white matter neurons express less reelin and are abnormally distributed in schizophrenia: towards an integration of molecular and morphologic aspects of the neurodevelopmental hypothesis. Mol. Psychiatry 8, 769, 731-821.
40. Eastwood S.L., and Harrison P.J. Interstitial white matter neuron density in the dorsolateral prefrontal cortex and parahippocampal gyrus in schizophrenia. Schizophr. Res. 79 (2005) 181-188
41. Erlander M.G., and Tobin A.J. The structural and functional heterogeneity of glutamic acid decarboxylase: a review. Neurochem. Res. 16 (1991) 215-226
42. Fagiolini M., and Hensch T.K. Inhibitory threshold for critical-period activation in primary visual cortex. Nature 404 (2000) 183-186
43. Fatemi, S.H., Earle, J.A., McMenomy, T., 2000. Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression, Mol. Psychiatry 5, 654-663, 571.
44. Fatemi S.H., Halt A.R., Stary J.M., Kanodia R., Schulz S.C., and Realmuto G.R. Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices. Biol. Psychiatry 52 (2002) 805-810
45. Fatemi S.H., Stary J.M., Earle J.A., Araghi-Niknam M., and Eagan E. GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and Reelin proteins in cerebellum. Schizophr. Res. 72 (2005) 109-122
46. Flores G., Alquicer G., Silva-Gomez A.B., Zaldivar G., Stewart J., Quirion R., and Srivastava L.K. Alterations in dendritic morphology of prefrontal cortical and nucleus accumbens neurons in post-pubertal rats after neonatal excitotoxic lesions of the ventral hippocampus. Neuroscience 133 (2005) 463-470
47. Fukuda T., Aika Y., Heizmann C.W., and Kosaka T. GABAergic axon terminals at perisomatic and dendritic inhibitory sites show different immunoreactivities against two GAD isoforms, GAD67 and GAD65, in the mouse hippocampus: a digitized quantitative analysis. J. Comp. Neurol. 395 (1998) 177-194
48. Gierdalski M., Jablonska B., Smith A., Skangiel-Kramska J., and Kossut M. Deafferentation induced changes in GAD67 and GluR2 mRNA expression in mouse somatosensory cortex. Brain Res. Mol. Brain Res. 71 (1999) 111-119
49. Goff D.C., and Evins A.E. Negative symptoms in schizophrenia: neurobiological models and treatment response. Harv. Rev. Psychiatry 6 (1998) 59-77
50. Grayson D.R., Jia X., Chen Y., Sharma R.P., Mitchell C.P., Guidotti A., and Costa E. Reelin promoter hypermethylation in schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 9341-9346
51. Guidotti A., Auta J., Davis J.M., Di-Giorgi-Gerevini V., Dwivedi Y., Grayson D.R., Impagnatiello F., Pandey G., Pesold C., Sharma R., Uzunov D., and Costa E. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch. Gen. Psychiatry 57 (2000) 1061-1069
52. Guidotti A., Auta J., Davis J.M., Dong E., Grayson D.R., Veldic M., Zhang X., and Costa E. GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon. Psychopharmacology (Berlin) 180 (2005) 191-205
53. Hakak Y., Walker J.R., Li C., Wong W.H., Davis K.L., Buxbaum J.D., Haroutunian V., and Fienberg A.A. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 4746-4751
54. Harrison P.J., and Weinberger D.R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol. Psychiatry 10 (2005) 40-68 (image 45)
55. Hashimoto T., Volk D.W., Eggan S.M., Mirnics K., Pierri J.N., Sun Z., Sampson A.R., and Lewis D.A. Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J. Neurosci. 23 (2003) 6315-6326
56. Hashimoto T., Bergen S.E., Nguyen Q.L., Xu B., Monteggia L.M., Pierri J.N., Sun Z., Sampson A.R., and Lewis D.A. Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia. J. Neurosci. 25 (2005) 372-383
57. Hassel B., Johannessen C.U., Sonnewald U., and Fonnum F. Quantification of the GABA shunt and the importance of the GABA shunt versus the 2-oxoglutarate dehydrogenase pathway in GABAergic neurons. J. Neurochem. 71 (1998) 1511-1518
58. Heckers S., Stone D., Walsh J., Shick J., Koul P., and Benes F.M. Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia. Arch. Gen. Psychiatry 59 (2002) 521-529
59. Heldt S.A., Green A., and Ressler K.J. Prepulse inhibition deficits in GAD65 knockout mice and the effect of antipsychotic treatment. Neuropsychopharmacology 29 (2004) 1610-1619
60. Hendry S.H., and Jones E.G. Reduction in number of immunostained GABAergic neurones in deprived-eye dominance columns of monkey area 17. Nature 320 (1986) 750-753
61. Huang Z.J., Kirkwood A., Pizzorusso T., Porciatti V., Morales B., Bear M.F., Maffei L., and Tonegawa S. BDNF regulates the maturation of inhibition and the critical period of plasticity in mouse visual cortex. Cell 98 (1999) 739-755
62. Ikeda K., Ikeda K., Iritani S., Ueno H., and Niizato K. Distribution of neuropeptide Y interneurons in the dorsal prefrontal cortex of schizophrenia. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 28 (2004) 379-383
63. Impagnatiello F., Guidotti A.R., Pesold C., Dwivedi Y., Caruncho H., Pisu M.G., Uzunov D.P., Smalheiser N.R., Davis J.M., Pandey G.N., Pappas G.D., Tueting P., Sharma R.P., and Costa E. A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 15718-15723
64. Jin X., Hu H., Mathers P.H., and Agmon A. Brain-derived neurotrophic factor mediates activity-dependent dendritic growth in nonpyramidal neocortical interneurons in developing organotypic cultures. J. Neurosci. 23 (2003) 5662-5673
65. Jolkkonen J., Jenner P., and Marsden C.D. GABAergic modulation of striatal peptide expression in rats and the alterations induced by dopamine antagonist treatment. Neurosci. Lett. 180 (1994) 273-276
66. Jones E.G., and Akbarian S. Potential mechanisms of defective brain development in schizophrenia. In: Mednick S.A. (Ed). Neural Development and Schizophrenia (1995), Plenum Press, New York 27-56
67. Kalkman H.O., and Loetscher E. GAD(67): the link between the GABA-deficit hypothesis and the dopaminergic and glutamatergic theories of psychosis. J. Neural Transm. 110 (2003) 803-812
68. Kanold P.O. Transient microcircuits formed by subplate neurons and their role in functional development of thalamocortical connections. NeuroReport 15 (2004) 2149-2153
69. Kash S.F., Johnson R.S., Tecott L.H., Noebels J.L., Mayfield R.D., Hanahan D., and Baekkeskov S. Epilepsy in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 14060-14065
70. Kaufman D.L., Houser C.R., and Tobin A.J. Two forms of the gamma-aminobutyric acid synthetic enzyme glutamate decarboxylase have distinct intraneuronal distributions and cofactor interactions. J. Neurochem. 56 (1991) 720-723
71. Kinney J.W., Davis C.N., Tabarean I., Conti B., Bartfai T., and Behrens M.M. A specific role for NR2A-containing NMDA receptors in the maintenance of parvalbumin and GAD67 immunoreactivity in cultured interneurons. J. Neurosci. 26 (2006) 1604-1615
72. Kirkpatrick B., Conley R.C., Kakoyannis A., Reep R.L., and Roberts R.C. Interstitial cells of the white matter in the inferior parietal cortex in schizophrenia: an unbiased cell-counting study. Synapse 34 (1999) 95-102
73. Kirkpatrick B., Messias N.C., Conley R.R., and Roberts R.C. Interstitial cells of the white matter in the dorsolateral prefrontal cortex in deficit and nondeficit schizophrenia. J. Nerv. Ment. Dis. 191 (2003) 563-567
74. Knable, M.B., Barci, B.M., Webster, M.J., Meador-Woodruff, J., Torrey, E.F., 2004. Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium, Mol. Psychiatry 9, 609-620, 544.
75. Kuwana S., Okada Y., Sugawara Y., Tsunekawa N., and Obata K. Disturbance of neural respiratory control in neonatal mice lacking GABA synthesizing enzyme 67-kDa isoform of glutamic acid decarboxylase. Neuroscience 120 (2003) 861-870
76. Laprade N., and Soghomonian J.J. Differential regulation of mRNA levels encoding for the two isoforms of glutamate decarboxylase (GAD65 and GAD67) by dopamine receptors in the rat striatum. Brain Res. Mol. Brain Res. 34 (1995) 65-74
77. Lein E.S., Finney E.M., McQuillen P.S., and Shatz C.J. Subplate neuron ablation alters neurotrophin expression and ocular dominance column formation. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 13491-13495
78. Lewis D.A., Hashimoto T., and Volk D.W. Cortical inhibitory neurons and schizophrenia. Nat. Rev., Neurosci. 6 (2005) 312-324
79. Li Q., Clark S., Lewis D.V., and Wilson W.A. NMDA receptor antagonists disinhibit rat posterior cingulate and retrosplenial cortices: a potential mechanism of neurotoxicity. J. Neurosci. 22 (2002) 3070-3080
80. Lipska B.K., Lerman D.N., Khaing Z.Z., and Weinberger D.R. The neonatal ventral hippocampal lesion model of schizophrenia: effects on dopamine and GABA mRNA markers in the rat midbrain. Eur. J. Neurosci. 18 (2003) 3097-3104
81. Liu W.S., Pesold C., Rodriguez M.A., Carboni G., Auta J., Lacor P., Larson J., Condie B.G., Guidotti A., and Costa E. Down-regulation of dendritic spine and glutamic acid decarboxylase 67 expressions in the reelin haploinsufficient heterozygous reeler mouse. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 3477-3482
82. Lundorf M.D., Buttenschon H.N., Foldager L., Blackwood D.H., Muir W.J., Murray V., Pelosi A.J., Kruse T.A., Ewald H., and Mors O. Mutational screening and association study of glutamate decarboxylase 1 as a candidate susceptibility gene for bipolar affective disorder and schizophrenia. Am. J. Med. Genet., Part B Neuropsychiatr. Genet. 135 (2005) 94-101
83. Lynex C.N., Carr I.M., Leek J.P., Achuthan R., Mitchell S., Maher E.R., Woods C.G., Bonthon D.T., and Markham A.F. Homozygosity for a missense mutation in the 67 kDa isoform of glutamate decarboxylase in a family with autosomal recessive spastic cerebral palsy: parallels with Stiff-Person Syndrome and other movement disorders. BMC Neurol. 4 (2004) 20
84. Mackie M., Hughes D.I., Maxwell D.J., Tillakaratne N.J., and Todd A.J. Distribution and colocalisation of glutamate decarboxylase isoforms in the rat spinal cord. Neuroscience 119 (2003) 461-472
85. Marty S., Berzaghi Mda P., and Berninger B. Neurotrophins and activity-dependent plasticity of cortical interneurons. Trends Neurosci. 20 (1997) 198-202
86. Mason G.F., Martin D.L., Martin S.B., Manor D., Sibson N.R., Patel A., Rothman D.L., and Behar K.L. Decrease in GABA synthesis rate in rat cortex following GABA-transaminase inhibition correlates with the decrease in GAD(67) protein. Brain Res. 914 (2001) 81-91
87. Mirnics K., Middleton F.A., Marquez A., Lewis D.A., and Levitt P. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 28 (2000) 53-67
88. Nicolson R., and Rapoport J.L. Childhood-onset schizophrenia: rare but worth studying. Biol. Psychiatry 46 (1999) 1418-1428
89. Noh J.S., Sharma R.P., Veldic M., Salvacion A.A., Jia X., Chen Y., Costa E., Guidotti A., and Grayson D.R. DNA methyltransferase 1 regulates reelin mRNA expression in mouse primary cortical cultures. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 1749-1754
90. Okhotin V.E., and Kalinichenko S.G. Interstitial cells of subcortical white matter, their connections, neurochemical specialization, and the role in histogenesis of the cortex. Morfologiia 121 (2002) 7-26
91. Panicker A.K., Buhusi M., Thelen K., and Maness P.F. Cellular signalling mechanisms of neural cell adhesion molecules. Front. Biosci. 8 (2003) d900-d911
92. Pappas G.D., Kriho V., and Pesold C. Reelin in the extracellular matrix and dendritic spines of the cortex and hippocampus: a comparison between wild type and heterozygous reeler mice by immunoelectron microscopy. J. Neurocytol. 30 (2001) 413-425
93. Paulson L., Martin P., Persson A., Nilsson C.L., Ljung E., Westman-Brinkmalm A., Eriksson P.S., Blennow K., and Davidsson P. Comparative genome- and proteome analysis of cerebral cortex from MK-801-treated rats. J. Neurosci. Res. 71 (2003) 526-533
94. Pesold C., Impagnatiello F., Pisu M.G., Uzunov D.P., Costa E., Guidotti A., and Caruncho H.J. Reelin is preferentially expressed in neurons synthesizing gamma-aminobutyric acid in cortex and hippocampus of adult rats. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 3221-3226
95. Pesold C., Pisu M.G., Impagnatiello F., Uzunov D.P., and Caruncho H.J. Simultaneous detection of glutamic acid decarboxylase and reelin mRNA in adult rat neurons using in situ hybridization and immunofluorescence. Brain Res. Brain Res. Protoc. 3 (1998) 155-160
96. Pillai-Nair N., Panicker A.K., Rodriguiz R.M., Gilmore K.L., Demyanenko G.P., Huang J.Z., Wetsel W.C., and Maness P.F. Neural cell adhesion molecule-secreting transgenic mice display abnormalities in GABAergic interneurons and alterations in behavior. J. Neurosci. 25 (2005) 4659-4671
97. Qin Z.H., Zhang S.P., and Weiss B. Dopaminergic and glutamatergic blocking drugs differentially regulate glutamic acid decarboxylase mRNA in mouse brain. Brain Res. Mol. Brain Res. 21 (1994) 293-302
98. Rapoport J.L., Addington A.M., Frangou S., and Psych M.R. The neurodevelopmental model of schizophrenia: update 2005. Mol. Psychiatry 10 (2005) 434-449
99. Ringstedt T., Linnarsson S., Wagner J., Lendahl U., Kokaia Z., Arenas E., Ernfors P., and Ibanez C.F. BDNF regulates reelin expression and Cajal-Retzius cell development in the cerebral cortex. Neuron 21 (1998) 305-315
100. Rioux L., Nissanov J., Lauber K., Bilker W.B., and Arnold S.E. Distribution of microtubule-associated protein MAP2-immunoreactive interstitial neurons in the parahippocampal white matter in subjects with schizophrenia. Am. J. Psychiatry 160 (2003) 149-155
101. Roberts R.C., Xu L., Roche J.K., and Kirkpatrick B. Ultrastructural localization of reelin in the cortex in post-mortem human brain. J. Comp. Neurol. 482 (2005) 294-308
102. Rodriguez M.A., Caruncho H.J., Costa E., Pesold C., Liu W.S., and Guidotti A. In Patas monkey, glutamic acid decarboxylase-67 and reelin mRNA coexpression varies in a manner dependent on layers and cortical areas. J. Comp. Neurol. 451 (2002) 279-288
103. Rougon G., and Hobert O. New insights into the diversity and function of neuronal immunoglobulin superfamily molecules. Annu. Rev. Neurosci. 26 (2003) 207-238
104. Rupniak N.M., Prestwich S.A., Horton R.W., Jenner P., and Marsden C.D. Alterations in cerebral glutamic acid decarboxylase and 3H-flunitrazepam binding during continuous treatment of rats for up to 1 year with haloperidol, sulpiride or clozapine. J. Neural Transm. 68 (1987) 113-125
105. Rutherford L.C., DeWan A., Lauer H.M., and Turrigiano G.G. Brain-derived neurotrophic factor mediates the activity-dependent regulation of inhibition in neocortical cultures. J. Neurosci. 17 (1997) 4527-4535
106. Sakai K., Gao X.M., Hashimoto T., and Tamminga C.A. Traditional and new antipsychotic drugs differentially alter neurotransmission markers in basal ganglia-thalamocortical neural pathways. Synapse 39 (2001) 152-160
107. Sarnat H.B., and Flores-Sarnat L. Role of Cajal-Retzius and subplate neurons in cerebral cortical development. Semin. Pediatr. Neurol. 9 (2002) 302-308
108. Shetty A.K., and Turner D.A. Glutamic acid decarboxylase-67-positive hippocampal interneurons undergo a permanent reduction in number following kainic acid-induced degeneration of ca3 pyramidal neurons. Exp. Neurol. 169 (2001) 276-297
109. Soghomonian J.J., and Laprade N. Glutamate decarboxylase (GAD67 and GAD65) gene expression is increased in a subpopulation of neurons in the putamen of Parkinsonian monkeys. Synapse 27 (1997) 122-132
110. Soghomonian J.J., and Martin D.L. Two isoforms of glutamate decarboxylase: why?. Trends Pharmacol. Sci. 19 (1998) 500-505
111. Takahashi M., Shirakawa O., Toyooka K., Kitamura N., Hashimoto T., Maeda K., Koizumi S., Wakabayashi K., Takahashi H., Someya T., and Nawa H. Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients. Mol. Psychiatry 5 (2000) 293-300
112. Tian N., Petersen C., Kash S., Baekkeskov S., Copenhagen D., and Nicoll R. The role of the synthetic enzyme GAD65 in the control of neuronal gamma-aminobutyric acid release. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 12911-12916
113. Todtenkopf M.S., and Benes F.M. Distribution of glutamate decarboxylase65 immunoreactive puncta on pyramidal and nonpyramidal neurons in hippocampus of schizophrenic brain. Synapse 29 (1998) 323-332
114. Torrey E.F., Barci B.M., Webster M.J., Bartko J.J., Meador-Woodruff J.H., and Knable M.B. Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains. Biol. Psychiatry 57 (2005) 252-260
115. Tremolizzo L., Carboni G., Ruzicka W.B., Mitchell C.P., Sugaya I., Tueting P., Sharma R., Grayson D.R., Costa E., and Guidotti A. An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 17095-17100
116. Tremolizzo L., Doueiri M.S., Dong E., Grayson D.R., Davis J., Pinna G., Tueting P., Rodriguez-Menendez V., Costa E., and Guidotti A. Valproate corrects the schizophrenia-like epigenetic behavioral modifications induced by methionine in mice. Biol. Psychiatry 57 (2005) 500-509
117. Tsunekawa N., Arata A., and Obata K. Development of spontaneous mouth/tongue movement and related neural activity, and their repression in fetal mice lacking glutamate decarboxylase 67. Eur. J. Neurosci. 21 (2005) 173-178
118. Ulfig N., Neudorfer F., and Bohl J. Transient structures of the human fetal brain: subplate, thalamic reticular complex, ganglionic eminence. Histol. Histopathol. 15 (2000) 771-790
119. Vawter M.P., Cannon-Spoor H.E., Hemperly J.J., Hyde T.M., VanderPutten D.M., Kleinman J.E., and Freed W.J. Abnormal expression of cell recognition molecules in schizophrenia. Exp. Neurol. 149 (1998) 424-432
120. Veldic M., Caruncho H.J., Liu W.S., Davis J., Satta R., Grayson D.R., Guidotti A., and Costa E. DNA-methyltransferase 1 mRNA is selectively overexpressed in telencephalic GABAergic interneurons of schizophrenia brains. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 348-353
121. Veldic M., Guidotti A., Maloku E., Davis J.M., and Costa E. In psychosis, cortical interneurons overexpress DNA-methyltransferase 1. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 2152-2157
122. Volk D.W., Austin M.C., Pierri J.N., Sampson A.R., and Lewis D.A. Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Arch. Gen. Psychiatry 57 (2000) 237-245
123. Weickert C.S., Hyde T.M., Lipska B.K., Herman M.M., Weinberger D.R., and Kleinman J.E. Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Mol. Psychiatry 8 (2003) 592-610
124. Weickert C.S., Ligons D.L., Romanczyk T., Ungaro G., Hyde T.M., Herman M.M., Weinberger D.R., and Kleinman J.E. Reductions in neurotrophin receptor mRNAs in the prefrontal cortex of patients with schizophrenia. Mol. Psychiatry 10 (2005) 637-650
125. Wolkin A., Sanfilipo M., Wolf A.P., Angrist B., Brodie J.D., and Rotrosen J. Negative symptoms and hypofrontality in chronic schizophrenia. Arch. Gen. Psychiatry 49 (1992) 959-965
126. Woo T.U., Walsh J.P., and Benes F.M. Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-d-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder. Arch. Gen. Psychiatry 61 (2004) 649-657
127. Zhang B., Yuan Y., Jia Y., Yu X., Xu Q., Shen Y., and Shen Y. An association study between polymorphisms in five genes in glutamate and GABA pathway and paranoid schizophrenia. Eur. Psychiatry 20 (2005) 45-49
128. Zink M., Schmitt A., May B., Muller B., Demirakca T., Braus D.F., and Henn F.A. Differential effects of long-term treatment with clozapine or haloperidol on GABAA receptor binding and GAD67 expression. Schizophr. Res. 66 (2004) 151-157